Academic Journal
Q1Cancer Discovery
About Cancer Discovery
Cancer Discovery is a scholarly journal published by American Association for Cancer Research Inc.. SCImago 2025 places it in Q1 with an SJR of 7.389 and an H-index of 265.
Its listed coverage is 2011-2026 and its research categories include Oncology (Q1). The 2025 dataset reports 170 documents and 12992 citations across the latest three-year reporting window.
Cancer has been one of the most persistent challenges in medical science. Over the years, researchers and scientists have worked tirelessly to understand the complexities of this disease, which affects millions of people worldwide. The discovery of new methods to detect, treat, and ultimately cure cancer has been a significant focus in the medical community. In recent years, several groundbreaking discoveries have revolutionized cancer research, bringing hope to patients and healthcare providers alike.
What Is Cancer and Why Is It So Challenging?
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells. The complexity of cancer arises from its ability to develop in almost any part of the body, leading to numerous types, including breast cancer, lung cancer, leukemia, and more. Each type of cancer behaves differently, making treatment and early detection a significant challenge. Despite the advancements in treatment over the past few decades, cancer remains one of the leading causes of death globally.
A Leap Forward: Recent Discoveries in Cancer Research
Over the past few years, there have been remarkable discoveries that have changed the way we approach cancer treatment. Some of the most significant advances include the following:
1. Immunotherapy: The Power of the Immune System
Immunotherapy is one of the most promising breakthroughs in cancer research. It harnesses the body's immune system to fight cancer. Traditional cancer treatments, such as chemotherapy and radiation, target cancer cells directly, often damaging healthy cells in the process. Immunotherapy, on the other hand, strengthens the immune system's ability to recognize and destroy cancer cells. Some types of immunotherapy have already been approved for treating cancers like melanoma and lung cancer, offering hope for patients who previously had limited options.
2. Liquid Biopsies: A Non-Invasive Diagnostic Tool
Liquid biopsies have revolutionized the way doctors detect cancer. Unlike traditional biopsies, which require tissue samples from the tumor, liquid biopsies use blood samples to identify cancer-related genetic material. This non-invasive approach offers a faster, safer, and more cost-effective way to detect cancer in its early stages. Liquid biopsies are also being explored for monitoring cancer treatment progress, potentially allowing doctors to adjust treatment plans in real time.
3. CRISPR Gene Editing: Targeting Cancer at Its Roots
Gene editing technology, particularly CRISPR-Cas9, has made significant strides in cancer research. CRISPR allows scientists to make precise changes to the DNA of living cells, offering the potential to correct genetic mutations that cause cancer. Researchers are investigating the use of CRISPR to target specific genes responsible for the development of various cancers, offering a more personalized approach to treatment. While still in the experimental phase, CRISPR has the potential to revolutionize cancer therapies in the near future.
4. Artificial Intelligence (AI) in Cancer Research
Artificial intelligence has begun to play an increasingly important role in cancer research. AI algorithms can analyze vast amounts of medical data, including imaging scans, genetic information, and patient histories, to identify patterns that human doctors may miss. AI-powered tools are also being used to develop new drugs and predict which treatments are most likely to be effective for individual patients. This technology has the potential to significantly accelerate the discovery of new cancer treatments and improve patient outcomes.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Cancer, a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, has long been one of the most formidable challenges in the field of medicine. However, with constant advancements in cancer research, the scope of cancer discovery has expanded exponentially, offering hope for new treatments, improved survival rates, and enhanced quality of life for millions of individuals globally.
The Evolving Landscape of Cancer Research
The field of cancer research is vast, continuously evolving with new discoveries, innovative treatments, and the development of advanced technologies. Researchers are delving deeper into the genetic and molecular mechanisms that underlie cancer, helping to identify potential targets for new therapies. This expanding understanding of cancer biology has paved the way for the development of precision medicine, where treatments are tailored to individual genetic profiles, offering more effective and less toxic options than traditional chemotherapy.
One of the most exciting frontiers in cancer discovery is the exploration of immunotherapy. Immunotherapy leverages the body’s immune system to recognize and destroy cancer cells. Researchers are now able to develop immune checkpoint inhibitors, CAR T-cell therapies, and cancer vaccines that have shown promising results in treating previously difficult-to-treat cancers like melanoma, lung cancer, and certain types of leukemia.
Genetic and Molecular Advancements
The role of genetics in cancer discovery cannot be overstated. Advances in genomics, fueled by technologies such as next-generation sequencing, have enabled scientists to decode the genetic makeup of tumors more efficiently. This has led to the identification of specific mutations that drive cancer, as well as potential biomarkers that can be used for early detection, diagnosis, and prognosis. Personalized medicine, driven by these genetic insights, offers the promise of more targeted and effective therapies.
Furthermore, the field of epigenetics is also gaining momentum in cancer research. Epigenetic changes, which affect gene expression without altering the DNA sequence, play a significant role in the development and progression of cancer. By understanding these changes, researchers hope to uncover new therapeutic strategies that could prevent or reverse cancer cell growth.
Early Detection and Screening
Early detection of cancer remains one of the most effective ways to improve outcomes and survival rates. The scope of cancer discovery has led to the development of more advanced screening methods, such as liquid biopsy. Liquid biopsy allows for the detection of cancer-related genetic mutations and alterations through a simple blood test, making it a non-invasive and highly promising tool for early detection.
Moreover, advancements in imaging technologies, such as AI-powered radiology, have improved the accuracy of tumor detection. These technologies can analyze medical images with a level of precision that surpasses human capability, ensuring that tumors are detected at earlier, more treatable stages.
Precision Medicine and Targeted Therapies
The shift toward precision medicine has been one of the most profound changes in the cancer treatment landscape. By analyzing the genetic and molecular profiles of both patients and tumors, doctors can choose the most effective treatment options. Targeted therapies, which focus on specific molecules involved in cancer cell growth, have proven to be highly effective for certain types of cancer, including breast, lung, and colorectal cancers.
Targeted therapies have fewer side effects compared to traditional chemotherapy, as they specifically target cancer cells without harming healthy tissue. This approach, coupled with advancements in immunotherapy and other innovative treatments, has transformed the outlook for patients diagnosed with cancer.
Recent Research Articles
Latest publications matched automatically by ISSN.
Germline Differences Influence Tumor Evolutionary Trajectories
2026-09-08 · DOI: 10.1158/2159-8290.cd-rw2026-080Q&A: Keith Flaherty on Advances in Cancer Research
2026-09-08 · DOI: 10.1158/2159-8290.cd-nw2026-0087Mismatch Repair–Proficient Colorectal Cancer Can Evade Immune Surveillance through an Intrinsic Suppressive Program
Chiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, Vittoria Matafora et al.
2026-09-07 · DOI: 10.1158/2159-8290.cd-26-0542The Landscape of Prostate Tumor Methylation
Jaron Arbet, Takafumi N. Yamaguchi, Yu-Jia Shiah, Rupert Hugh-White et al.
2026-09-07 · DOI: 10.1158/2159-8290.cd-25-0761Gut Pathobionts Translocate into the Liver and Reshape Intrahepatic Microbiome to Facilitate Hepatocellular Carcinoma
Weixin Liu, Xueliang Wang, Ying Zhang, Jinkai Liu et al.
2026-09-07 · DOI: 10.1158/2159-8290.cd-25-1355Non-Hallucinogenic LSD Analogue Boosts Immune Response to Colorectal Cancer
2026-09-04 · DOI: 10.1158/2159-8290.cd-rw2026-079New Studies Showcase Capabilities of Organoids
2026-09-04 · DOI: 10.1158/2159-8290.cd-nw2026-0086A Foundation Model of Cancer Genotype Enables Precise Predictions of Therapeutic Response
JungHo Kong, Ingoo Lee, Dean Boecher, Akshat Singhal et al.
2026-09-03 · DOI: 10.1158/2159-8290.cd-25-1735Pan-RAS Inhibitor Shows Activity in Advanced Lung Cancer
2026-09-03 · DOI: 10.1158/2159-8290.cd-nw2026-0085Functionally active lymphoid aggregates correlate with improved prognosis in brain metastases
Noor E. Nader, Alexandra R. Glathar, Elaine V. Byrnes, Marion Joy et al.
2026-09-02 · DOI: 10.1158/2159-8290.cd-25-0731Highlighted Research Articles
2026-09-01 · DOI: 10.1158/2159-8290.cd-16-9-itiMitochondrial Complex I at the Crossroads of NK cell Dysfunction in Glioblastoma
Silvia Tiberti, Katayoun Rezvani, May Daher
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-1267Translational Challenges and Opportunities in mRNA Cancer Vaccines
Seong Dong Jeong, Benjamin R. Schrank, James J. Mancuso, Betty Y.S. Kim et al.
2026-09-01 · DOI: 10.1158/2159-8290.cd-25-1456Insights on Future Directions in Cancer Research from the AACR Trailblazer Cancer Research Grant Awardees
Ana Luísa Correia, Karen O. Dixon, J. Justin Milner, Nathan H. Parker et al.
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-1356Malignant Transition in Three Dimensions
Zehua Jing, Mingyao Li
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-1266Following the Genetic Breadcrumbs of MPNs
Gaurav Agarwal, Vijay G. Sankaran
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-1265Long-Read Haplotype Phasing Resolves Allelic Configuration as a Missing Layer of Precision Oncology
Josh N. Vo, Yi-Mi Wu, Rui Wang, Tiffany Pham et al.
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-0839Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia
Juliano Machado, Vignesh Karthikaisamy, Hermine Mohr, Doris Kaltenecker et al.
2026-09-01 · DOI: 10.1158/2159-8290.cd-26-0045Immune Concept–Informed AI Improves Immunotherapy Response Prediction
2026-09-01 · DOI: 10.1158/2159-8290.cd-rw2026-078Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer
Ahmed M. Elhossiny, Padma Kadiyala, Jude O. Okoye, Harrison L. Hiraki et al.
2026-08-31 · DOI: 10.1158/2159-8290.cd-25-2001Reviews
Community Reviews
Version History
April 18, 2025 at 10:05 am
April 18, 2025